Used in research as a synthetic intermediate for developing psychoactive compounds related to harmala alkaloids. Shows potential in studies involving monoamine oxidase inhibition, which may influence mood and neurological activity. Investigated for its role in enhancing the effects of certain neurotransmitters due to its interaction with enzyme systems in the brain. Also explored for possible applications in treating neurological disorders, though primarily limited to laboratory and preclinical settings. Not used in commercial pharmaceuticals or consumer products.